Occupational exposure to HIV and the use of post-exposure prophylaxis

Occupational Medicine

Volumn 57, Issue 5, 2007, Pages 329-336

  Hamlyn, Elizabeth ^a   Easterbrook, Philippa ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

HIV; Occupational exposure; Post exposure prophylaxis

Indexed keywords

ABACAVIR; AMPRENAVIR PHOSPHATE; ANTIRETROVIRUS AGENT; DOMPERIDONE; EFAVIRENZ; EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; HEPATITIS B VACCINE; INDINAVIR; LAMIVUDINE; LAMIVUDINE PLUS ZIDOVUDINE; LOPERAMIDE; LOPINAVIR; LOPINAVIR PLUS RITONAVIR; NELFINAVIR; NEVIRAPINE; NUCLEOSIDE ANALOG; PEGINTERFERON; PROTEINASE INHIBITOR; RIBAVIRIN; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; STAVUDINE; TENOFOVIR; ZIDOVUDINE;

CHOLESTATIC HEPATITIS; CLINICAL TRIAL; DIARRHEA; DRUG HYPERSENSITIVITY; DRUG WITHDRAWAL; GALACTORRHEA; HEALTH CARE PERSONNEL; HEPATITIS B; HEPATITIS C; HIGH RISK PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERPROLACTINEMIA; LIVER FAILURE; MEDICOLEGAL ASPECT; NAUSEA; NEEDLESTICK INJURY; NONHUMAN; OCCUPATIONAL ACCIDENT; OCCUPATIONAL DISEASE; OCCUPATIONAL EXPOSURE; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; REVIEW; SEROCONVERSION; UNSPECIFIED SIDE EFFECT; VIRUS TRANSMISSION;

ANTI-RETROVIRAL AGENTS; DISEASE TRANSMISSION, PATIENT-TO-PROFESSIONAL; GREAT BRITAIN; HEALTH PERSONNEL; HIV INFECTIONS; HUMANS; OCCUPATIONAL DISEASES; OCCUPATIONAL EXPOSURE; RISK;

EID: 34547914815     PISSN: 09627480     EISSN: 14718405     Source Type: Journal    
DOI: 10.1093/occmed/kqm046     Document Type: Review

References (45)

1. Sonder GJ, Bovee LP, Coutinho RA, Baayen D, Spaargaren J, van den Hoek A. Occupational exposure to bloodborne viruses in the Amsterdam police force. Am J Prev Med 2005;28:169-174.
2. Gent AM, Zuckerman J. A review of the infection control policies for bloodborne viruses as applied to non-governmental organisations (NGOs). Travel Med Infect Dis 2003;1:29-33.
3. UK Health Departments. Guidance for Clinical Health Care Workers: Protection against Infection with Blood Borne Viruses; Recommendations of the Expert Advisoyy Group on AIDS and the Advisory Group on Hepatitis [HSC 1998/063], Department of Health 1998 www.dh.goc.uk.
4. Beekmann SE, Henderson DK. Protection of healthcare workers from bloodborne pathogens. Curr Opin Infect Dis 2005;18:331-336.
5. Pruss-Ustun A, Rapiti E, Hutin Y. Sharps Injuries: Global Burden of Disease from Sharps Injuries to Health-Care Workers. WHO Environmental Burden of Disease Series, No. 3. Geneva, Switzerland: World Health Organization, 2003.
6. Nsubuga FM, Jaakkola MS. Needle stick injuries among nurses in sub-Saharan Africa. Trop Med Int Health 2005;10:773-781.
7. Doebbeling BN, Vaughn TE, McCoy KD et al. Percutaneous injury, blood exposure, and adherence to standard precautions: Are hospital-based health care providers still at risk? Clin Infect Dis 2003;37:1006-1013.
8. Chen MY, Fox EF, Rogers CA. Post-exposure prophylaxis for human immunodeficiency virus: Knowledge and experience of junior doctors. Sex Transm Infect 2001;77:444-445.
9. Johnston, JJE, O'Conor E. Needlestick injuries, management and education: A role for emergency medicine? Eur J Emerg Med 2005; 12:10-12.
10. Ooi C, Dayan L, Yee L. Knowledge of post exposure prophylaxis (PEP) for HIV among general practitioners in northern Sydney. Sex Transm Infect 2004;80:420.
11. Tsai CC, Emau P, Sun JC et al. Post-exposure chemoprophylaxis (PECP) against SIV infection of macaques as a model for protection from HIV infection. J Med Primatol 2000;29:248-258.
12. Tsai CC, Follis KE, Sabo A et al. Prevention of SIV infection in macaques by (R)-9-(2 phosphonylmethoxypropyl) adenine. Science 1995;270:1197-1199.
13. Tsai CC, Emau P, Follis KE et al. Effectiveness of post-inoculation (R)-9-(2-phosphonylmethoxypropyl) adenine treatment for prevention of persistent simian immunodeficiency virus SIVmne infection depends critically on timing of initiation and duration of treatment. J Virol 1998;72:4265-4273.
14. Van Rompay KK, McChesney MB, Aguirre NL, Schmidt KA, Bischofberger N, Marthas ML. Two low doses of tenofovir protect newborn macaques against oral simian immunodeficiency virus infection. J Infect Dis 2001; 184:429-438.
15. Böttiger D, Johansson NG, Samuelsson B et al. Prevention of simian immunodeficiency virus, SIVsm, or HIV-2 infection in cynomolgus monkeys by pre- and postexposure administration of BEA-005. AIDS 1997;11:157-162.
16. Cardo DM, Culver DH, Ciesielski CA et al. A case-control study of HIV seroconversion in health care workers after percutaneous exposure. N Engl J Med 1997;337: 1485-1490.
17. Connor EM, Sperling RS, Gelber R et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 1994;331:1173-1180.
18. Mofenson LM, Lambert JS, Stiehm ER et al. Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team. N Engl J Med 1999;341:385-393.
19. Sperling RS, Shapiro DE, Coombs RW et al. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 1996;335:1621-1629.
20. Wade NA, Birkhead GS, Warren BL et al. Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus. N Engl J Med 1998;339:1409-1414.
21. Fisher M, Benn P, Evans B et al. Clinical Effectiveness Group (British Association for Sexual Health and HIV). UK Guideline for the use of post-exposure prophylaxis for HIV following sexual exposure. Int J STD AIDS 2006;17:81-92.
22. Schechter M, do Lago RF, Mendelsohn AB et al. Behavioral impact, acceptability, and HIV incidence among homosexual men with access to postexposure chemoprophylaxis for HIV. J Acquir Immune Defic Syndr 2004;35:519-525.
23. HIV and STI Division Communicable Disease Surveillance Centre and Collaborators. Occupational Transmission of HIV. Summary of Published Reports. December 1999 Edition. Data to the End of June 1999.
24. Quinn TC, Wawer MJ, Sewankambo N et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med 2000;342:921-929.
25. Department of Health. HIV Post Exposure Prophylaxis Guidance from the UK Chief Medical Qfficers Expert Advisory Group on AIDS, Department of Health 2004 www.dh.goc.uk.
26. Landrum ML, Wilson CH, Perri LP, Hannibal SL, O'Connell RJ. Usefulness of a rapid human immunodeficiency virus-1 antibody test for the management of occupational exposure to blood and body fluid. Infect Control Hosp Epidemiol 2005;26:768-774.
27. King AM, Osterwalder JJ, Vernazza PL. A randomised prospective study to evaluate a rapid HIV-antibody assay in the management of cases of percutaneous exposure amongst health care workers. Swiss Med Wkly 2001;131:10-13.
28. Puro V, Cicalini S, De Carli G et al. Post-exposure prophylaxis of HIV infection in healthcare workers: Recommendations for the European setting. Eur J Epidemiol 2004;19:577-584.
29. Panlilio AL, Cardo DM, Grohskopf LA, Heneine W, Ross CS. Updated U.S. Public Health Service Guidelines for the Management of Occupational Exposures to HIV and Recommendations for Postexposure Prophylaxis. Morb Mortal Wkly Rep 2005;54:1-17.
30. El-Far F, Medeiros EA, Gasparoto CT, Diaz RS. Antiretroviral drug resistance among patients with human immunodeficiency virus who act as sources or potential sources in occupational accidents involving healthcare workers. Infect Control Hosp Epidemiol 2005;26: 782-788.
31. Beltrami EM, Cheingsong R, Heneine WM et al. Occupational HIV Exposure Study Group. Antiretroviral drug resistance in human immunodeficiency virus-infected source patients for occupational exposures to healthcare workers. Infect Control Hosp Epidemiol 2003;24:724-730.
32. Beltrami EM, Luo CC, de la Torre N, Cardo DM. Transmission of drug-resistant HIV after an occupational exposure despite postexposure prophylaxis with a combination drug regimen. Infect Control Hosp Epidemiol 2002;23: 345-348.
33. Parkin JM, Murphy M, Anderson J, El-Gadi S, Forster G, Pinching AJ. Tolerability and side-effects of post-exposure prophylaxis for HIV infection. Lancet 2000;355:722-723.
34. Braitstein P, Chan K, Beardsell A et al. Safety and tolerability of combination antiretroviral post-exposure prophylaxis in a population-based setting. J Acquir Immune Defic Syndr 2002;29 547-548.
35. Winston A, McAllister J, Amin J, Cooper DA, Carr A. The use of a triple nucleoside-nucleotide regimen for nonoccupational HIV post-exposure prophylaxis. HIV Med 2005;6:191-197.
36. Quirino T, Niero F, Ricci E et al. HAART tolerability: post-exposure prophylaxis in healthcare workers versus treatment in HIV-infected patients. Antivir Ther 2000;5:195-197.
37. Worthington MG, Ross JJ, Bergeron EK. Posttraumatic stress disorder after occupational HIV exposure: Two cases and a literature review. Infect Control Hosp Epidemiol 2006; 27:215-217.
38. Trape M, Barnosky S. Nelfinavir in expanded postexposure prophylaxis causing acute hepatitis with cholestatic features: Two case reports. Infect Control Hosp Epidemiol 2001;22:333-334.
39. Sha BE, Proia LA, Kessler HA. Adverse effects associated with use of nevirapine in HIV postexposure prophylaxis for 2 health care workers. J Am Med Assoc 2000;284:2723.
40. British HIV Association. Guidelines for the Management of HIV Infection in Pregnant Women and the Prevention of Mother-To-Child Transmission of HIV. http://bhiva.org (May 2006, date last accessed).
41. Puro V, De Carli G, Cicalini S et al. European recommendations for the management of healthcare workers occupationally exposed to hepatitis B virus and hepatitis C virus. Euro Surveill 2005;10:260-264.
42. Jaeckel E, Cornberg M, Wederneyer H et al. Treatment of acute hepatitis C with interferon alfa-2b. N Engl J Med 2001;345 1452-1457.
43. Evans BG, Abiteboul D. A summary of occupationally acquired HIV infections described in published reports to December 1997. Euro Surveill 1999;4:29-32.
44. Hawkins DA, Asboe D, Barlow K, Evans B. Seroconversion to HIV-1 following a needlestick injury despite combination post-exposure prophylaxis. J Infect 2001;43:12-15.
45. Health Protection Agency Centre for Infections and Collaborators. Occupational Transmission of HIV. Summary of Published Reports. Data to the End of December 2002. March 2005 Edition.